KLK3 and prostate cancer: Using the Bayesian approach described above, we estimated the probability of advanced prostate cancer at the time of diagnosis for different levels of total PSA in the plasma obtained from the 142 cases (88%) and 382 controls who were ages 44–50 at baseline venipuncture (Figures 2 and 3).